📝 Medico Intercontinental Ltd — results explained
Quarter ended June 2026 (Q1 FY27)
Medico Intercontinental Ltd reported revenue of ₹14 crore for the quarter ended June 2026 (Q1 FY27), up 6.4% from ₹13 crore in the same quarter last year, and down 9.4% sequentially over the March 2026 quarter.
Net profit rose 8.9% year-on-year to ₹1 crore, from ₹1 crore. Earnings per share (EPS) came in at ₹0.61.
Operating profit stood at ₹0 crore — an operating margin (OPM) of 3.5%, compared with 8.2% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Medico Intercontinental Ltd posted revenue of ₹54 crore, a decline of 18.9% over FY25, with a net profit of ₹2 crore (down 15.2% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹55 crore with a net profit of ₹2 crore.
Valuation snapshot
At the current price of ₹25.90, 539938 has a market capitalisation of ₹25 crore and a trailing P/E of about 11.3.
Within the Trading & Distributors industry, it is the 25th-largest of the 178 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 58.51%, public shareholders 41.48% of Medico Intercontinental Ltd.
Promoter holding rose from 57.15% to 58.51% over the latest period.